Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry R Davis

Showing results (71-80 of 185) with videos related to

Pageof 19
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2014
Rapid decreases in blood pressure from antihypertensive treatment were associated with increased cancer mortality in the Systolic Hypertension in the Elderly ProgramJoel N Swerdel, Teresa M Janevic, Javier Cabrera, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 26, 2016
Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHATJeff Whittle, Amy I Lynch, Rikki M Tanner, et al.
Plos One|September 3, 2011
Pharmacogenetic associations of MMP9 and MMP12 variants with cardiovascular disease in patients with hypertensionRikki M Tanner, Amy I Lynch, Victoria H Brophy, et al.
American Journal of Hematology|July 26, 2017
Kidney function of transfused children with sickle cell anemia: Baseline data from the TWiTCH study with comparison to non-transfused cohortsOfelia Alvarez, Kerri Nottage, Lara M Simpson, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 14, 2019
Sustained blood pressure control and coronary heart disease, stroke, heart failure, and mortality: An observational analysis of ALLHATC Barrett Bowling, Barry R Davis, Alison Luciano, et al.
Journal of Hypertension|October 5, 2019
Lack of a significant legacy effect of baseline blood pressure 'treatment naivety' on all-cause and cardiovascular mortality in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialChau L B Ho, Monique Breslin, Enayet K Chowdhury, et al.
Circulation|January 21, 2004
Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trialVerghese Mathew, Bernard J Gersh, Brent A Williams, et al.
European Heart Journal|December 12, 2025
Blood pressure lowering in isolated diastolic hypertension and cardiovascular risk: an individual patient data meta-analysisZeinab Bidel, Milad Nazarzadeh, Dexter Canoy, et al.
The American Surgeon|March 27, 2014
DeBakey type II aortic dissection: a rare catastrophic complication of pregnancyBryan C Morse, Brian N Boland, Jessica N Morse, et al.
Circulation|May 22, 2002
Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) ProjectMarc A Pfeffer, Anthony Keech, Frank M Sacks, et al.
Pageof 19

Showing results (71-80 of 185) with videos related to

Sort By:
Pageof 19
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2014
Rapid decreases in blood pressure from antihypertensive treatment were associated with increased cancer mortality in the Systolic Hypertension in the Elderly ProgramJoel N Swerdel, Teresa M Janevic, Javier Cabrera, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 26, 2016
Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHATJeff Whittle, Amy I Lynch, Rikki M Tanner, et al.
Plos One|September 3, 2011
Pharmacogenetic associations of MMP9 and MMP12 variants with cardiovascular disease in patients with hypertensionRikki M Tanner, Amy I Lynch, Victoria H Brophy, et al.
American Journal of Hematology|July 26, 2017
Kidney function of transfused children with sickle cell anemia: Baseline data from the TWiTCH study with comparison to non-transfused cohortsOfelia Alvarez, Kerri Nottage, Lara M Simpson, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 14, 2019
Sustained blood pressure control and coronary heart disease, stroke, heart failure, and mortality: An observational analysis of ALLHATC Barrett Bowling, Barry R Davis, Alison Luciano, et al.
Journal of Hypertension|October 5, 2019
Lack of a significant legacy effect of baseline blood pressure 'treatment naivety' on all-cause and cardiovascular mortality in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialChau L B Ho, Monique Breslin, Enayet K Chowdhury, et al.
Circulation|January 21, 2004
Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trialVerghese Mathew, Bernard J Gersh, Brent A Williams, et al.
European Heart Journal|December 12, 2025
Blood pressure lowering in isolated diastolic hypertension and cardiovascular risk: an individual patient data meta-analysisZeinab Bidel, Milad Nazarzadeh, Dexter Canoy, et al.
The American Surgeon|March 27, 2014
DeBakey type II aortic dissection: a rare catastrophic complication of pregnancyBryan C Morse, Brian N Boland, Jessica N Morse, et al.
Circulation|May 22, 2002
Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) ProjectMarc A Pfeffer, Anthony Keech, Frank M Sacks, et al.
Pageof 19